CODA Biotherapeutics

CODA Biotherapeutics is a preclinical-stage biopharmaceutical company dedicated to developing innovative gene therapies for the treatment of various diseases. The company is utilizing a revolutionary chemogenetics-based technology to modulate the activity of pathological cells, with the goal of genetically modifying target cell populations to express regulatable "switch" proteins. Cells modified with the "switch" can be activated or inactivated in a dose-dependent manner by subsequent administration of small molecule therapeutics, with this effect occurring only in the modified cells.